Cartilage Regeneration in Osteoarthritic Patients by a Composite of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells and Hyaluronate Hydrogel: Results from a Clinical Trial for Safety and Proof-of-Concept with 7 Years of Extended Follow-Up
Tóm tắt
Few methods are available to regenerate articular cartilage defects in patients with osteoarthritis. We aimed to assess the safety and efficacy of articular cartilage regeneration by a novel medicinal product composed of allogeneic human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs). Patients with Kellgren-Lawrence grade 3 osteoarthritis and International Cartilage Repair Society (ICRS) grade 4 cartilage defects were enrolled in this clinical trial. The stem cell-based medicinal product (a composite of culture-expanded allogeneic hUCB-MSCs and hyaluronic acid hydrogel [Cartistem]) was applied to the lesion site. Safety was assessed by the World Health Organization common toxicity criteria. The primary efficacy outcome was ICRS cartilage repair assessed by arthroscopy at 12 weeks. The secondary efficacy outcome was visual analog scale (VAS) score for pain on walking. During a 7-year extended follow-up, we evaluated safety, VAS score, International Knee Documentation Committee (IKDC) subjective score, magnetic resonance imaging (MRI) findings, and histological evaluations. Seven participants were enrolled. Maturing repair tissue was observed at the 12-week arthroscopic evaluation. The VAS and IKDC scores were improved at 24 weeks. The improved clinical outcomes were stable over 7 years of follow-up. The histological findings at 1 year showed hyaline-like cartilage. MRI at 3 years showed persistence of the regenerated cartilage. Only five mild to moderate treatment-emergent adverse events were observed. There were no cases of osteogenesis or tumorigenesis over 7 years. The application of this novel stem cell-based medicinal product appears to be safe and effective for the regeneration of durable articular cartilage in osteoarthritic knees.
Từ khóa
Tài liệu tham khảo
Seo, 2011, Management of focal chondral lesion in the knee joint, Knee Surg Relat Res, 23, 185, 10.5792/ksrr.2011.23.4.185
Goyal, 2013, Evidence-based status of microfracture technique: A systematic review of level I and II studies, Arthroscopy, 29, 1579, 10.1016/j.arthro.2013.05.027
Mithoefer, 2009, Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: An evidence-based systematic analysis, Am J Sports Med, 37, 2053, 10.1177/0363546508328414
Lee, 2013, Results of microfracture in the osteoarthritic knee with focal full-thickness articular cartilage defects and concomitant medial meniscal tears, Knee Surg Relat Res, 25, 71, 10.5792/ksrr.2013.25.2.71
Martin, 2003, The role of chondrocyte senescence in the pathogenesis of osteoarthritis and in limiting cartilage repair, J Bone Joint Surg Am, 85-A, 106, 10.2106/00004623-200300002-00014
Tuan, 2003, Adult mesenchymal stem cells and cell-based tissue engineering, Arthritis Res Ther, 5, 32, 10.1186/ar614
Koh, 2013, Mesenchymal stem cell injections improve symptoms of knee osteoarthritis, Arthroscopy, 29, 748, 10.1016/j.arthro.2012.11.017
Ha, 2014, Mesenchymal stem cells versus fat pad-derived cells, Arthroscopy, 30, 419, 10.1016/j.arthro.2014.01.015
Varma, 2010, The new avenues in the management of osteo-arthritis of knee––stem cells, J Indian Med Assoc, 108, 583
Jo, 2014, Intra-articular injection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: A proof-of-concept clinical trial, Stem Cells, 32, 1254, 10.1002/stem.1634
Wakitani, 2002, Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees, Osteoarthritis Cartilage, 10, 199, 10.1053/joca.2001.0504
Wakitani, 2011, Safety of autologous bone marrow-derived mesenchymal stem cell transplantation for cartilage repair in 41 patients with 45 joints followed for up to 11 years and 5 months, J Tissue Eng Regen Med, 5, 146, 10.1002/term.299
Flynn, 2007, UC blood-derived mesenchymal stromal cells: An overview, Cytotherapy, 9, 717, 10.1080/14653240701584578
Kern, 2006, Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue, Stem Cells, 24, 1294, 10.1634/stemcells.2005-0342
Chung, 2014, Comparison of articular cartilage repair with different hydrogel-human umbilical cord blood-derived mesenchymal stem cell composites in a rat model, Stem Cell Res Ther, 5, 39, 10.1186/scrt427
Yang, 2004, Mesenchymal stem/progenitor cells developed in cultures from UC blood, Cytotherapy, 6, 476, 10.1080/14653240410005041
Trotti, 2003, CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment, Semin Radiat Oncol, 13, 176, 10.1016/S1053-4296(03)00031-6
Smith, 2005, Arthroscopic assessment of cartilage repair: A validation study of 2 scoring systems, Arthroscopy, 21, 1462, 10.1016/j.arthro.2005.09.007
Watanabe, 2006, Delayed gadolinium-enhanced MR to determine glycosaminoglycan concentration in reparative cartilage after autologous chondrocyte implantation: Preliminary results, Radiology, 239, 201, 10.1148/radiol.2383050173
Veronesi, 2013, Clinical use of bone marrow, bone marrow concentrate, and expanded bone marrow mesenchymal stem cells in cartilage disease, Stem Cells Dev, 22, 181, 10.1089/scd.2012.0373
Zhang, 2011, Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue, J Cell Biochem, 112, 1206, 10.1002/jcb.23042
Roura, 2015, The role and potential of umbilical cord blood in an era of new therapies: A review, Stem Cell Res Ther, 6, 123, 10.1186/s13287-015-0113-2
Park, 2015, Cartilage repair by human umbilical cord blood-derived mesenchymal stem cells with different hydrogels in a rat model, J Orthop Res, 33, 1580, 10.1002/jor.22950
Ha, 2015, Cartilage repair using composites of human umbilical cord blood-derived mesenchymal stem cells and hyaluronic acid hydrogel in a minipig model, Stem Cells Translational Medicine, 4, 1044, 10.5966/sctm.2014-0264
Lee, 2014, Low immunogenicity of allogeneic human umbilical cord blood-derived mesenchymal stem cells in vitro and in vivo, Biochem Biophys Res Commun, 446, 983, 10.1016/j.bbrc.2014.03.051
Aggarwal, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, 1815, 10.1182/blood-2004-04-1559
Sato, 2012, Direct transplantation of mesenchymal stem cells into the knee joints of Hartley strain guinea pigs with spontaneous osteoarthritis, Arthritis Res Ther, 14, R31, 10.1186/ar3735
Jeong, 2013, Thrombospondin-2 secreted by human umbilical cord blood-derived mesenchymal stem cells promotes chondrogenic differentiation, Stem Cells, 31, 2136, 10.1002/stem.1471
Brown, 2014, Temporal in vivo assessment of fresh osteochondral allograft transplants to the distal aspect of the femur by dGEMRIC (delayed gadolinium-enhanced MRI of cartilage) and zonal T2 mapping MRI, J Bone Joint Surg Am, 96, 564, 10.2106/JBJS.K.01456
Mithoefer, 2005, The microfracture technique for the treatment of articular cartilage lesions in the knee. A prospective cohort study, J Bone Joint Surg Am, 87, 1911, 10.2106/JBJS.D.02846
Williams, 2007, Microfracture: Indications, technique, and results, Instr Course Lect, 56, 419